YIDU TECH (02158) wins bid for major public health project in Hainan, with a project amount of nearly 13 million RMB.

YIDU TECH (02158) has recently shown strong momentum in business expansion. Following the announcement of winning the bid for the AI construction project in cooperation with Beijing University Cancer Hospital (amounting to approximately RMB 4.88 million) earlier, the company announced today that it has won the bid for the Infectious Disease Monitoring and Early Warning Emergency Command Information Platform project in Hainan Province's integrated regional area for nearly RMB 12.89 million. These two winning bids are seen as a double breakthrough for the company in the commercialization of medical AI large-scale models and the intelligentization of public health. Market analysis interprets the Beijing University Cancer Hospital project as a key milestone for YIDU TECH in the implementation of medical AI large-scale models. This cooperation will use a top domestic cancer specialty institution as a benchmark scenario to provide a demonstration basis for the large-scale expansion of medical large models in specialized clinical pathways. The Hainan public health project further consolidates the company's digital service capabilities in public health at the government end and forms a dual-drive pattern of "hospital end + public health end". On April 9th, YIDU TECH held a "Medical Navigation Intelligent Exploration" special investor exchange conference, attracting nearly a hundred representatives from well-known domestic and foreign funds and mainstream brokerage institutions. The clinically evidence-based intelligent body "Medical Navigation Intelligent Exploration" showcased at the conference received high recognition from investors due to its deep understanding of the clinical workflow of doctors and its potential new business model. Based on the positive progress mentioned above, Citibank recently released a research report, reiterating a "buy" rating for YIDU TECH and giving a target price of HKD 11.00. Citibank believes that the launch of "Medical Navigation Intelligent Exploration" is expected to deepen the company's connection with the doctor community, strengthen its big data platform and solution (BDPS) business within the hospital network, and open up a new token-based payment model. The report specifically points out that compared to similar products launched by internet companies, YIDU TECH's core advantage lies in its deep connection with medical data within hospitals and a more profound understanding of clinical scenarios. Successive major projects and positive institutional ratings demonstrate the dual progress of YIDU TECH in technical commercialization and market trust building. Analysts point out that with the promotion of innovative products such as "Medical Navigation Intelligent Exploration," the company is expected to evolve from a project-based model to a more sustainable, usage-based service model in the medical AI field.